3186 results for «3639»
3186 results
Valve selection in urgent TAVI: evidence from small annulus studies - Hotline
16 Nov 2025 – From PCR London Valves 2025
This session presents cutting-edge research comparing self-expanding and balloon-expandable valves in urgent and emergent TAVI settings, with a focus on small aortic annuli. It includes data from the NAVULTRA and LANDMARK trials, featuring novel biomimetic balloon-expandable valves and early feasibility studies that shed light on valve...
Hotline - Mitral and tricuspid valvular interventions
16 Nov 2025 – From PCR London Valves 2025
This session delves into innovative mitral and tricuspid valvular interventions, highlighting outcomes with the PASCAL precision system and advances in combined MitraClip and TriClip repairs. It discusses predictors of heart failure hospitalization post-transcatheter tricuspid valve repair (TTVR), coronary CT-based pacemaker implantation prediction, and novel devices aimed...
Shaping the future: top innovations at PCR London Valves 2025
16 Nov 2025 – From PCR London Valves 2025
Highlighting transformative innovations from PCR London Valves 2025, this session features advanced technologies such as the Luna TMVR with its unique intuitive design, the novel Tripair technology for tricuspid therapy, and insights into right heart remodeling following transcatheter tricuspid valve interventions with the DUO system, showcasing...
Featured research: clinical outcomes and real-world evidence in modern TAVI practice
16 Nov 2025 – From PCR London Valves 2025
This session presents featured research on Transcatheter Aortic Valve Implantation (TAVI), analyzing clinical impacts of prosthesis oversizing, same-day discharge experiences, and comparative outcomes of intra-annular versus supra-annular self-expanding valves. It also reviews nationwide TAVR data from Germany and meta-analyses assessing TAVI performance in centers without on-site...
Complex mitral and tricuspid TEER
16 Nov 2025 – From PCR London Valves 2025
This session highlights complex cases in mitral and tricuspid transcatheter edge-to-edge repair (TEER), addressing challenges such as septal obstacles in patients with old atrial septal occluders, management of residual atrial septal defects post-mitral valve-in-ring replacement, and innovative multidisciplinary approaches. It also covers hybrid transapical mitral valve-in-valve...
PCR London Valves 2025 Welcome Ceremony
16 Nov 2025 – From PCR London Valves 2025
The PCR London Valves 2025 Welcome Ceremony marks the commencement of the conference, setting the stage for an immersive exploration of the latest advances and innovations in valvular heart disease management with a focus on transcatheter interventions.
Retrieval of embolised devices
16 Nov 2025 – From PCR London Valves 2025
This session delves into the complex scenarios of embolised device retrieval, exploring various interventions such as management of Lambre device embolisation, alternatives to surgery for superior vena cava baffle stent embolisation, novel strategies for chronically embolised Gore Helex atrial septal occluder device retrieval, and challenging redo...
Redo TAVI with pre and post dilatation - LIVE Case
16 Nov 2025 – From PCR London Valves 2025
Watch this live case followed by a live in a box case, regarding a 93-year-old woman with hypertension, chronic bronchitis, and a history of TAVI with a Sapien 3 23 mm (2016) who presented with symptomatic severe aortic stenosis and mildly reduced LV function (50%). An...
The Silk Road of MedTech
16 Nov 2025 – From PCR London Valves 2025
Discover pioneering MedTech innovations along the Silk Road, including novel sheath designs for minimalist TAVR, self-expanding valves for pure aortic regurgitation, automated CT quantification via deep learning, and first-in-man experiences with cutting-edge valvuloplasty and TEER devices.
Innovations in TAVR: clinical insights and future perspectives
16 Nov 2025 – From PCR London Valves 2025
Presenting featured research on TAVI, this session covers outcomes from centers without on-site cardiac surgery, comparative leaflet modification techniques, conscious sedation protocols, left ventricular health in timing TAVR, and long-term valve durability insights including seven-year follow-up data.
Cutting-edge research in transcatheter tricuspid valve therapies
16 Nov 2025 – From PCR London Valves 2025
This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.
TAVI in bicuspid anatomy
16 Nov 2025 – From PCR London Valves 2025
Explore the complexities of performing TAVI in bicuspid aortic valve anatomies, with expert discussions on BASILICA tricuspidisation, procedural planning for extreme calcification, valve sizing, and challenges associated with type 0 bicuspid valves and severe calcification.
TAVI valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
This session presents complex valve-in-valve TAVI cases, illustrating advanced techniques such as valve fracture and snaring in difficult anatomies, approaches for pure aortic regurgitation in degenerated surgical valves, and strategies overcoming challenges in stentless bioprostheses and previous aortic repairs.
Challenging mitral valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
Gain insights into challenging mitral valve-in-valve procedures addressing small cavity anatomy, alignment difficulties, combined LAMPOON and leak closure techniques, and high-risk TMVR cases with complex left ventricular outflow tract obstruction and ECMO support.
New tricuspid valve devices
16 Nov 2025 – From PCR London Valves 2025
Examine new tricuspid valve devices and innovative procedural approaches, featuring cases of challenging anatomy with pacemaker lead repositioning, use of LuX-valve plus in massive regurgitation, position optimization in transjugular TTVR, and early clinical experiences from feasibility studies.
Curious TAVI scenarios: from valve-in-valve challenges to life-saving emergency TAVI
16 Nov 2025 – From PCR London Valves 2025
This session presents a series of challenging and unusual TAVI cases, addressing complex scenarios such as persistent gradients after valve-in-valve procedures, advanced sealing techniques for nodules, innovative snare methods, emergency TAVI following diagnostic catheterisation, combined aortic valve and aorta interventions, and the crucial role of echocardiography...
Late-breaking evidence in structural and coronary interventions - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...
New approaches in aortic regurgitation
16 Nov 2025 – From PCR London Valves 2025
Explore new diagnostic and therapeutic approaches for managing aortic regurgitation. This session covers imaging modalities, guideline-directed patient selection, current transcatheter treatment techniques, and emerging TAVI technologies designed specifically for non-calcific aortic valve pathology.
Emergency transcatheter valve interventions: alternative therapy or bridge to surgery?
16 Nov 2025 – From PCR London Valves 2025
This session offers a compelling case-based exploration of emergency transcatheter valve interventions, demonstrating their potential as life-saving alternatives or bridges to surgery in high-risk patients. Through detailed clinical scenarios including cardiogenic shock, acute papillary muscle rupture, and severe aortic regurgitation from infective endocarditis, participants gain practical...
Procedural imaging for tricuspid valve interventions
16 Nov 2025 – From PCR London Valves 2025
Master procedural imaging techniques essential for tricuspid valve interventions, including TOE views, multi-phase reconstruction, and 3D/4D steering. This session also covers quantification of residual tricuspid regurgitation post-device deployment and the appropriate use of intracardiac echocardiography.
